Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: Meta-analysis of phase III trials

Geoffrey Y. Ku, Benjamin A. Haaland, Gilberto de Lima Lopes

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: Meta-analysis of phase III trials'. Together they form a unique fingerprint.

Medicine & Life Sciences